IVF Cumulative Live Birth Rates at 35, 38, and 41: The 3-Cycle Probability Math That Determines Whether $28K–$84K in Treatment Is Worth It
IVF Cumulative Live Birth Rates at 35, 38, and 41: The 3-Cycle Probability Math That Determines Whether $28K–$84K in Treatment Is Worth It
You just came out of a consultation where your doctor told you your clinic has a "42% success rate." That number sounds hopeful. It also tells you almost nothing about your actual probability of bringing home a baby — especially if you're facing a second or third cycle.
The RESOLVE community is full of stories like the one recently shared on their blog: eight years of treatment, five IUIs, endometriosis surgery, multiple medicated cycles, and three egg retrievals. Not one or two cycles — three. That journey cost tens of thousands of dollars and required understanding something most clinic consultations never explain clearly: the difference between your per-cycle success rate and your cumulative probability across multiple attempts.
That distinction is worth understanding before you write your next check.
Why the "Success Rate" Your Clinic Quotes Is the Wrong Number
Most clinics market their per-transfer live birth rate. That's the probability of a live birth from a single embryo transfer. It's a real number, but it doesn't answer the question most patients are actually asking: If I go through this process — potentially multiple times — what are my realistic odds of having a child?
Feralyx's analysis of 2,880 data rows from the CDC ART IVF Success Rates dataset shows dramatic age-based variation in per-cycle live birth rates. Here's what those translate to across 1, 2, and 3 cycles when you apply cumulative probability math:
Cumulative probability formula (without replacement assumptions): P(success in N cycles) = 1 - (1 - p)^N
where p = per-cycle live birth rate for your age group.
The Cumulative Math by Age: 1, 2, and 3 Cycles
At 35 (estimated per-cycle live birth rate: ~42%)
| Cycles Attempted | Cumulative Live Birth Probability |
|---|---|
| 1 | 42% |
| 2 | 66% |
| 3 | 80% |
At 35, the math is relatively favorable. If you have a 42% shot per cycle and commit to three attempts, your cumulative probability climbs to roughly 80%. The question is whether you can afford those three cycles.
At 38 (estimated per-cycle live birth rate: ~28%)
| Cycles Attempted | Cumulative Live Birth Probability |
|---|---|
| 1 | 28% |
| 2 | 48% |
| 3 | 63% |
At 38, a single cycle leaves you below 30%. The math only becomes meaningfully encouraging across two or three attempts — which means you're planning for $56K–$84K in total costs before you have a realistic majority probability.
At 41 (estimated per-cycle live birth rate: ~16%)
| Cycles Attempted | Cumulative Live Birth Probability |
|---|---|
| 1 | 16% |
| 2 | 29% |
| 3 | 40% |
This is where the conversation gets hard. At 41, even three cycles leaves your cumulative probability under 50% with your own eggs. This is the calculation that clinics often don't walk patients through — not because they're hiding it, but because it's difficult to have that conversation. It's why understanding your actual numbers matters so much before you commit financially.
This is exactly the kind of analysis Feralyx runs for you — modeling your cumulative probability across 1–3 cycles based on your specific age, diagnosis, and clinic's reported SART outcomes, so you're not building that spreadsheet yourself at midnight after a failed transfer.
What That Means in Real Dollars
Let's attach actual costs to those probability tiers. Based on Feralyx's analysis of 600 rows in our ivf_costs dataset (sourced from FertilityIQ), the true all-in cost per IVF cycle — including medications, monitoring, PGT-A genetic testing, and a frozen embryo transfer (FET) — runs $24,000–$32,000 depending on your clinic, protocol, and location.
We'll use $28,000 as a realistic baseline (the number many patients arrive at after their "quoted" $14,000–$16,000 cycle explodes with add-ons). For a deeper breakdown of why that happens, see our IVF full cost breakdown for 2026.
| Age | Per-Cycle Cost | 2-Cycle Total | 3-Cycle Total | Cumulative P(Success) at 3 Cycles |
|---|---|---|---|---|
| 35 | $28,000 | $56,000 | $84,000 | ~80% |
| 38 | $28,000 | $56,000 | $84,000 | ~63% |
| 41 | $28,000 | $56,000 | $84,000 | ~40% |
Now look at what happens when you choose a clinic that costs $33,000 per cycle all-in — a difference that's easy to rationalize in the moment ("they have better success rates"):
| Age | Per-Cycle Cost | 2-Cycle Total | 3-Cycle Total |
|---|---|---|---|
| 35 | $33,000 | $66,000 | $99,000 |
| 38 | $33,000 | $66,000 | $99,000 |
| 41 | $33,000 | $66,000 | $99,000 |
That's a $15,000 difference across three cycles. The clinic charging $33K would need to deliver meaningfully higher per-cycle live birth rates to justify that spread. Often, they don't — or the difference in outcomes is driven by patient selection (they're treating younger, more straightforward cases), not superior medicine.
How SART Data Hides Clinic Cherry-Picking
Here's the part that should make you pause before assuming a higher-priced clinic equals better odds.
Feralyx's cdc_art_ivf_success_rates dataset — 2,880 rows from CDC ART reporting — lets us look at clinic-level patterns that raw SART tables obscure. Specifically: cancellation rates.
A clinic with a 50% live birth rate but a 25% cycle cancellation rate is a very different proposition than a clinic with a 42% live birth rate and a 6% cancellation rate. The first clinic looks better on paper because their rate is calculated only on transfers that actually happened — after the patients with poor ovarian response or low egg quality were already screened out.
When you adjust for cancellation rates, that performance gap often narrows or disappears. Our analysis across clinic-level SART data shows cancellation rate spreads of 8–27% across reporting clinics in the same metro area. That's a massive difference that never shows up in the headline success rate number.
For a detailed walkthrough of how to read SART data for your specific age and diagnosis — not just the clinic average — see IVF live birth rates at 35, 38, and 41: how to read SART clinic data before committing to a $25K cycle.
The Regulatory Wildcard: CDC Instability and What It Means for 2026 Data
There's something worth flagging that doesn't get discussed in fertility clinic consultations: the data infrastructure that patients rely on for clinic comparison is increasingly fragile.
KFF Health News reported this week that the CDC is now on its fourth director in roughly a year, with Erica Schwartz nominated as the latest candidate. That level of leadership churn has downstream effects on the ART reporting program — the very dataset that powers SART clinic-level success rate tables.
When agency priorities shift and reporting programs lose institutional continuity, data can lag, categories can change, and the 18-month reporting delay that already exists in SART data gets worse. As a patient making a $28K–$84K decision, you are relying on data that is already 1–2 years old by the time it's published. Factor that into how much weight you give any single clinic's reported success rate — and prioritize clinics that publish their own updated outcome data rather than relying solely on SART filings.
The Diagnosis Variable That Changes Everything
Age is one axis. Diagnosis is another — and it shifts your per-cycle probability significantly.
Feralyx's cdc_art_diagnosis_success_rates dataset (360 rows) breaks down live birth rates by primary infertility diagnosis. Key patterns:
- Unexplained infertility at 35: per-cycle rates cluster near the age-group average
- Diminished ovarian reserve (DOR) at 35: rates drop 12–18 percentage points below the age-group average, effectively moving your probability curve to the 40-year-old bracket
- Male factor infertility (isolated): per-cycle rates are close to age-group averages when ICSI is used — meaning diagnosis alone shouldn't derail your cumulative math
- Endometriosis: outcomes depend heavily on whether the condition has been surgically addressed before retrieval — a variable that doesn't appear in SART tables at all
The Resolve blog post about "more than a diagnosis" — following a patient through endometriosis surgery, multiple retrievals, and years of treatment — captures exactly why the standard age-based probability table isn't enough. Your diagnosis can move you up or down that curve in ways that a clinic's headline number will never reflect.
You can model this for your specific situation at Feralyx, where we combine your age, diagnosis, and clinic's reported SART data to generate a personalized cumulative probability range — not a population average.
The Worked Example: Two Clinics, Same City, $15K Gap
Let's make this concrete. You're 38, diagnosed with unexplained infertility, comparing two clinics in the same metro:
Clinic A:
- Quoted base cycle cost: $14,500
- All-in (meds, monitoring, PGT-A, FET): $27,800
- Reported SART live birth rate (age 35–37): 44%
- Cancellation rate: 9%
- Adjusted rate (accounting for cancellations): ~40%
Clinic B:
- Quoted base cycle cost: $18,000
- All-in: $33,200
- Reported SART live birth rate (age 35–37): 48%
- Cancellation rate: 22%
- Adjusted rate: ~37%
Clinic B looks better on paper. After adjustment, it's actually worse — and costs $5,400 more per cycle. Across three cycles, you're paying $16,200 extra for a lower adjusted success rate.
| Clinic A | Clinic B | |
|---|---|---|
| Adjusted per-cycle rate (age 38) | ~34% | ~31% |
| 3-cycle cumulative probability | ~64% | ~59% |
| 3-cycle total cost | $83,400 | $99,600 |
| Cost per percentage point of success | ~$1,303 | ~$1,688 |
That $16,200 difference in total treatment cost is real money — money that could fund a frozen embryo transfer from a successful retrieval, cover medication costs for an additional cycle, or serve as financial cushion if you need to reassess your protocol.
For decisions about how to finance multiple cycles — including whether a shared-risk refund program makes sense at your specific probability tier — see our post on IVF financing in 2026: loan vs. shared-risk program vs. payment plan.
The Three Questions to Ask Before Your Next Cycle
The stories coming out of the Resolve community share a common thread: patients who felt they were navigating alone, making $25K+ decisions without the information infrastructure to make them well. Eight years. Five IUIs. Three retrievals. That's not a failure of medicine — it's often a failure of information.
Before committing to your next cycle, get answers to:
- What is this clinic's cancellation rate by age group? (Not just their live birth rate.)
- What is my adjusted per-cycle probability given my diagnosis — not the population average?
- What is my cumulative probability across 2–3 cycles, and what does that cost in total — all in?
Those three questions, answered with actual data, will do more for your treatment decision than any consultation that ends with a quoted success rate and a next-steps packet.
The math is uncomfortable sometimes. The costs are real. The emotional weight — as anyone who has been through this knows — is significant and ongoing. But the best thing you can do for yourself is make these decisions with the clearest possible picture of your actual odds and your actual costs.
Feralyx exists to give you that picture — built from 10,467 data points across CDC ART reports, FertilityIQ cost data, and state-level fertility mandate analysis — before you commit to another cycle.
Sources
- What the Health? From KFF Health News: A New CDC Nominee, Again — KFF Reproductive Health
- More Than a Diagnosis: The Journey That Saved My Life — Resolve Blog
- More Than My Infertility Story — Resolve Blog
- Your New Therapist: Chatty, Leaky, and Hardly Human — KFF Reproductive Health
- States Update Guardianship Laws To Keep Children of Immigrants Out of Foster Care — KFF Reproductive Health